Regeneron Pharmaceuticals is on the cusp of unveiling its Q2 2025 earnings this Friday, with expectations pinned at $8.53 per share and a revenue forecast of $3.30 billion. Analysts are eyeing a ...

Neogen (NASDAQ:NEOG) is scheduled to announce Q4 earnings results on Tuesday, July 29th, before market open.The consensus EPS Estimate is $0.09 (-10.0% Y/Y) and the consensus Revenue Estimate is $222.

Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...

John G Ullman & Associates Inc. made a hefty bet on Regeneron Pharmaceuticals, upping their stake by a whopping 94%, now ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most profitable biotech stocks to invest in now. Canaccord ...

Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...

BOK Financial (BOKF) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook ...

A full preview of the New York Jets' 2025 defensive tackle group ahead of training camp highlighted by Quinnen Williams.

AI has powered the market to all-time highs. But this earnings season will be an important moment for Big Tech to show that massive AI spending is paying off. Here are three big questions ...

MLB Draft Preview in CardsMajor prospect ranking sites like Baseball America (BA), MLB Pipeline, and ESPN have been releasing mock first one drafts for several weeks leading up to the draft. As we ...